Basilea Pharmceutica NA buy Quitte
Start price
21.04.16
/
50%
€75.33
Target price
21.10.16
€79.00
Performance (%)
-13.13%
End price
21.10.16
€65.44
Summary
This prediction ended on 21.10.16 with a price of €65.44. The price of Basilea Pharmceutica NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.13%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Basilea Pharmceutica NA | - | - | - | - |
| iShares Core DAX® | -0.598% | 0.645% | 10.813% | 15.396% |
| iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% | 40.773% |
| iShares Nikkei 225® | -0.796% | -0.582% | 8.390% | 8.288% |
| iShares S&P 500 | -1.164% | -0.857% | 23.003% | 41.152% |
Comments by Quitte for this prediction
In the thread Basilea Pharmceutica NA diskutieren
Kampf gegen Hirntumor
Basilea berichtet über Präsentation von Daten zu den klinischen Onkologie-Kandidaten BAL101553 und BAL3833 auf AACR-Tagung
(Laufzeit überschritten)